Most notably, Dr. Hauer-Jensen was the founder and director of the division of radiation health from 2008 to 2023. He was named an emeritus professor in 2023.
LITTLE ROCK, AR, February 13, 2024 /24-7PressRelease/ -- Marquis Who's Who, the world's premier publisher of biographical profiles, is proud to present Martin Hauer-Jensen, MD, with the Albert Nelson Marquis Lifetime Achievement Award. An accomplished listee, Dr. Hauer-Jensen celebrates many years' experience in his professional network, and has been noted for achievements, leadership qualities, and the credentials and successes he has accrued in his field. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.
Dr. Hauer-Jensen has been lauded for his expertise in the medical field, having spent over 30 years in the health care sector. Having led a diverse, rewarding career, he was a general surgeon and researcher specializing in radiation and was highly successful in drug development. Splitting his time between clinical and classroom hours, Dr. Hauer-Jensen practiced medicine at The Norwegian Radium Hospital as a staff surgeon and director of the clinical trials office from 1989 to 1990 and then as a staff surgeon at Central Arkansas Veterans Healthcare System between 1991 and 2017. Additionally, he succeeded at the University of Arkansas for Medical Sciences (UAMS), beginning as an instructor in 1991 and rising to a full professor of surgery and pathology in 1999. At UAMS, Dr. Hauer-Jensen also served as a professor of pharmaceutical sciences. Most notably, Dr. Hauer-Jensen was the founder and director of the division of radiation health from 2008 to 2023. He was named an emeritus professor in 2023.
Throughout his distinguished career, Dr. Hauer-Jensen has found the most success in his research, which garnered the most impact. His years in research began in Norway and included a strong focus on radiation enteropathy and intestinal radiation injury, which had not been studied very much at the time. Dr. Hauer-Jensen subsequently became recognized for developing a model in the U.S. to give fractionated radiation to a segment of the small bowel, which drew tremendous success, has since been used repeatedly, and has been critical to his professional prowess in medicine.
Dr. Hauer-Jensen's research has notably been funded through the National Cancer Institute, the National Institute of Allergy and Infectious Disease, the National Institute of General Medical Sciences, the Defense Threat Reduction Agency, and the Biomedical Advanced Research and Development Agency. As a seasoned scholar, he has disseminated his findings by publishing over 300 scientific articles and several book chapters.
In retirement, Dr. Hauer-Jensen intends to remain active with various projects, including a radioprotector he is working on called Gamma Tocotrienol, which is very close to receiving approval from the Food and Drug Administration.
Dr. Hauer-Jensen immigrated to the U.S. in 1990. He graduated from the University of Oslo with a Doctor of Medicine and a Doctor of Philosophy in radiation biology in 1977 and 1988, respectively.
About Marquis Who's Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Marquis celebrates its 125th anniversary in 2023, and Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. Marquis® publications may be visited at the official Marquis Who's Who® website at www.marquiswhoswho.com.
# # #